Product Description: Tivozanib (AV-951; KRN951) is a selective, orally active inhibitor for vascular endothelial growth factor receptor (VEGFR)-1, 2 3, with IC50s of 30, 6.5 and 15 nM, respectively. Tivozanib exhibits antitumor efficacy[1].
Applications: Cancer-Kinase/protease
Formula: C22H19ClN4O5
References: [1]Nakamura K, et al., KRN951, a highly potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has antitumor activities and affects functional vascular properties. Cancer Res. 2006 Sep 15;66(18):9134-42.
CAS Number: 475108-18-0
Molecular Weight: 454.86
Compound Purity: 99.60
Research Area: Cancer
Solubility: DMSO : 25 mg/mL (ultrasonic)
Target: VEGFR